"10.1371_journal.pone.0071284","plos one","2013-08-20T00:00:00Z","Petra Suchankova; Pia Steensland; Ida Fredriksson; Jörgen A Engel; Elisabet Jerlhag","Institute of Neuroscience and Physiology, Department of Pharmacology, The Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden; Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden","Conceived and designed the experiments: P. Suchankova P. Steensland EJ. Performed the experiments: P. Suchankova P. Steensland EJ IF. Analyzed the data: P. Suchankova P. Steensland EJ. Contributed reagents/materials/analysis tools: P. Steensland JAE EJ. Wrote the paper: P. Suchankova P. Steensland EJ IF JAE.","The GHS-R1A antagonist JMV2959 was supplied by Æterna Zentaris. Prof. Jean Martinez and Dr. Jean-Alain Fehrentz are acknowledged for the synthesis of JMV2959. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.",23,1,1,"2013","08","Petra Suchankova","PS",5,TRUE,1,1,1,1,TRUE,TRUE,TRUE,3,"3;4;5",TRUE
